Please ensure Javascript is enabled for purposes of website accessibility

Why Palantir Stock Is Up Today

By Rich Smith - Updated Jan 15, 2021 at 11:51AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The sell-off is over. Let the momentum resume.

What happened

Shares of Palantir Technologies (PLTR -1.55%), the IT defense contractor, dropped hard earlier this week after analysts at Citigroup downgraded the stock to a sell rating with a $15 price target. Palantir had been trading north of $26 at the time, but investors were spooked by the megabank's negative tone, and spent the next two days selling off the stock, eventually sending it down nearly 5%.

Today, however, with the panic subsiding, investors are returning to Palantir in droves, and the stock was up 6.4% by 11 a.m. EST, above where it was when the sell-off started.

Stock up glowing green arrow climbs on a stock screen

Image source: Getty Images.

So what

On the one hand, nothing's really changed about Palantir's business except that one market participant (albeit a very influential one) expressed a change in opinion on the stock. That seems like a weak reason for everyone else selling the stock.

And yet the predictions Citi made in downgrading Palantir's stock haven't really had a chance to play out yet. As the analyst explained on Wednesday, there are a couple of negative catalysts awaiting Palantir investors in the year ahead. In the nearest term, the lockup period that prevents insiders from selling their shares will expire in mid-February, potentially unleashing a flood of new shares onto the market and depressing the stock price.    

Later in the year, Citi warns, multiple COVID-19-related contracts that Palantir won last year will approach their conclusion. If not renewed, this could depress sales and earnings at the tech specialist, and become "headwinds in the second half of 2021 and into 2022,"  TheFly.com reports.

Now what

That could be a concern if the contracts are not renewed. But just last month, the U.S. Army re-upped with Palantir on a data-analytics contract first awarded in December 2019 that is being used in the fight against COVID-19. While that contract's base portion ran for only one year, it contained options for renewal for as many as three additional years. And in this most recent renewal, the value awarded to Palantir actually increased, to $114 million.

Just two days after that, the United Kingdom signed a $31.5 million, two-year contract with Palantir to provide similar services to the National Health Service. And barely a week later, the company scored a $22.5 million contract with Japan's health service as well.  

It sure seems to me that Palantir's business is doing fine, and these health service contracts appear to be at little risk of going away anytime soon.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Palantir Technologies Inc. Stock Quote
Palantir Technologies Inc.
PLTR
$7.96 (-1.55%) $0.12

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
330%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/23/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.